title: What adversely affects the unborn--psychotropic drugs or maternal morbidity?
authors.affiliation: Hospital for Sick Children and University of Toronto, Toronto, Ontario, Canada gideon.koren@sickkids.ca.
authors.forename: Gideon
authors.initials: G
authors.lastname: Koren
mesh_terms: D014151:Anti-Anxiety Agents / Q000009:adverse effects*; D000928:Antidepressive Agents / Q000009:adverse effects*; D018692:Antimanic Agents / Q000009:adverse effects*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001724:Birth Weight; D005260:Female; D006801:Humans; D006993:Hypnotics and Sedatives / Q000009:adverse effects*; D007232:Infant, Newborn, Diseases / Q000453:epidemiology*; D001523:Mental Disorders / Q000453:epidemiology*; D011247:Pregnancy; D011248:Pregnancy Complications / Q000453:epidemiology*; D047928:Premature Birth / Q000453:epidemiology*; D011297:Prenatal Exposure Delayed Effects / Q000453:epidemiology*
chemical_list: D014151:Anti-Anxiety Agents; D000928:Antidepressive Agents; D018692:Antimanic Agents; D014150:Antipsychotic Agents; D006993:Hypnotics and Sedatives